Biomaterial-Based Immunotherapies Biomaterials enable precise modulation of immune responses in RA, targeting innate and adaptive immune cells to restore immune balance
His research laid the groundwork for developing semaglutide and other GLP-1 drugs, which are sold under the brand names Ozempic, Rybelsus, Mounjaro and others
In a phase 2 obesity trial, retatrutide demonstrated an average weight loss of 17.5% at 24 weeks and 24.2% at 48 weeks in the 12 mg dose group 7
In New York City, more and more people are turning to peptides to restore energy, improve focus, support weight loss, and keep their bodies performing at their best
Safety Considerations Peptides are generally well-tolerated, but risks include: A longevity-trained physician must supervise peptide therapy (Smith et al., 2020)